Medicare Will Pay Cost of GLP-1 Coverage After Insurer Pushback

Medicare delays GLP-1 coverage plan; interim program extended

Eli Lilly (LLY) stock and Novo Nordisk (NONOF) stock are in focus as Medicare extends interim coverage for GLP-1 weight loss drugs. Read more here.

Medicare will pay cost of GLP-1 coverage after insurer pushback

The federal government scrapped a plan to have health insurance companies fund coverage of obesity drugs for seniors, opting instead to pay for the medicine with taxpayer dollars through the end of next year.

Insurers refuse to join Medicare pilot offering weight loss drugs to seniors at steep discount

The Trump administration will keep low copays for seniors in place through 2027, funding the program a different way.

UnitedHealth Sees ‘Challenges’ With Medicare Obesity Program

Health insurers are raising questions about the Trump administration’s plan to cover obesity drugs in Medicare next year, casting doubt on whether enough insurers will sign on to the effort for it to launch as planned.

Medicare indefinitely delays pilot plan to cover weight loss drugs

The Centers for Medicare and Medicaid Services has delayed a key pilot program focused on Medicare coverage for obesity medications, after insurance plans indicated they wouldn’t participate at this time. Abe Sutton, head of the ...